Table 2.
Age (in years) group (n) | Non-specific inflammation/reactive hyperplasia n (%) | Tuberculosis n (%) | Cancer n (%) | X2 of goodness of fit, df, P |
---|---|---|---|---|
<14 (99) | ||||
Observed | 51 (51.5) | 36 (36.4) | 12 (12.1) | 23.5, 2, <0.001 |
Expected | 33 (33.33) | 33 (33.33) | 33 (33.33) | |
15–59 (276) | ||||
Observed | 60 (21.7) | 156 (56.5) | 60 (21.7) | 66.8, 2, <0.001 |
Expected | 92 (33.33) | 92 (33.33) | 92 (33.33) | |
≥60 (48) | ||||
Observed | 0 | 0 | 48 (100.0) | 96.0, 2, <0.001 |
Expected | 16 (33.33) | 16 (33.33) | 16 (33.33) |
X2 Chi square
df degree of freedom